Studies of chlorambucil-DNA adducts.
Chlorambucil (CLB) is a bifunctional nitrogen mustard whose therapeutic and major side-effects are thought to be caused by binding to DNA. HPLC analysis of hydrolyzed DNA from L1210 cells incubated with [14C]CLB generated two peaks of radioactivity, indicating the formation of two or more major adducts. Since DNA incubated with [14C]CLB in a cell-free system gave rise to the same profile, experiments were conducted with DNA from cells exposed to radiolabeled DNA precursors, which was then reacted with CLB. DNA containing [8-14C]guanine gave rise to one peak of radioactivity, while DNA containing [2,8-3H]adenine gave rise to two peaks. These peaks corresponded to the peaks seen in the experiment with intact L1210 cells treated with [14C]CLB. Experiments with DNA containing [5-3H]cytosine indicated that no cytosyl adducts were formed. No adducts were seen in hydrolysates prepared from labeled DNA incubated with drug solvent alone. These data indicate that the majority of adducts induced by CLB are guanyl adducts, but a substantial quantity of adenyl adducts has also been identified.
Bank
B B
BB
Department of Medicine, UMDNJ-New Jersey Medical School, Newark 07103.
D000818:Animals; D002250:Carbon Radioisotopes; D002474:Cell-Free System; D002699:Chlorambucil / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000378:metabolism*; D003847:Deoxyglucose; D007939:Leukemia L1210 / Q000378:metabolism*; D014316:Tritium; D014407:Tumor Cells, Cultured / Q000378:metabolism
D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm; D014316:Tritium; D002699:Chlorambucil; D003847:Deoxyglucose